TuisKHTRF • OTCMKTS
add
Knight Therapeutics Inc
Vorige sluiting
$4,46
Jaarwisseling
$3,48 - $4,55
Markkapitalisasie
607,63 m CAD
Gemiddelde volume
2,90 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
TSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CAD) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 96,86 m | 30,55% |
Bedryfskoste | 43,31 m | 26,28% |
Netto inkomste | 10,74 m | 144,13% |
Netto winsgrens | 11,08 | 133,79% |
Wins per aandeel | 0,11 | 175,39% |
EBITDA | 6,46 m | -17,88% |
Effektiewe belastingkoers | -36,32% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CAD) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 172,84 m | 1,75% |
Totale bates | 963,80 m | 1,94% |
Totale aanspreeklikheid | 168,69 m | -15,07% |
Totale ekwiteit | 795,10 m | — |
Uitstaande aandele | 100,05 m | — |
Prys om te bespreek | 0,56 | — |
Opbrengs op bates | -0,77% | — |
Opbrengs op kapitaal | -0,88% | — |
Kontantvloei
Netto kontantverandering
| (CAD) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 10,74 m | 144,13% |
Kontant van bedrywe | 1,47 m | -91,81% |
Kontant van beleggings | 18,05 m | 1 049,45% |
Kontant van finansiering | -15,35 m | 56,99% |
Netto kontantverandering | 6,35 m | 134,04% |
Beskikbare kontantvloei | 4,96 m | -91,80% |
Meer oor
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Gestig
2014
Hoofkwartier
Webwerf
Werknemers
745
